X4 Pharmaceuticals (XFOR) Change in Receivables (2017 - 2025)
X4 Pharmaceuticals posted quarterly Change in Receivables of -$318000.0 for Q4 2025, down 129.72% year-on-year from $1.1 million in Q4 2024, and down 25.2% on a QoQ basis from -$254000.0 in Q3 2025.
X4 Pharmaceuticals (XFOR) has 5 years of Change in Receivables data on file, last reported at -$318000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables fell 129.72% year-over-year to -$318000.0; the trailing twelve-month figure through Dec 2025 stood at -$497000.0 (down 146.45% YoY), and the FY2025 full-year result was -$497000.0, down 146.45% from the prior year.
- Change in Receivables for Q4 2025 stood at -$318000.0, down from -$254000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $1.1 million in Q4 2024 and bottomed at -$561000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 110.42 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | -318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -318,000.00 |
| Dec 31, 2025 | -318,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Jun 30, 2025 | 636,000.00 |
| Jun 30, 2025 | 636,000.00 |
| Mar 31, 2025 | -561,000.00 |
| Mar 31, 2025 | -561,000.00 |
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Mar 31, 2020 | 3.00 Mn |
| Mar 31, 2020 | 3.00 Mn |
| Dec 31, 2018 | -19,000.00 |
| Dec 31, 2018 | -19,000.00 |
| Sep 30, 2018 | -720,000.00 |
| Sep 30, 2018 | -720,000.00 |
| Jun 30, 2018 | -358,000.00 |
| Jun 30, 2018 | -358,000.00 |
| Mar 31, 2018 | -277,000.00 |
| Mar 31, 2018 | -277,000.00 |
| Dec 31, 2017 | -121,000.00 |
| Dec 31, 2017 | -121,000.00 |
| Sep 30, 2017 | 604,000.00 |
| Sep 30, 2017 | 604,000.00 |
| Jun 30, 2017 | -12,000.00 |
| Jun 30, 2017 | -12,000.00 |
| Mar 31, 2017 | -535,000.00 |
| Mar 31, 2017 | -535,000.00 |